drugset / Trial / NCT03968562
Assessment of Suppression of Cutaneous Allergic Responses and Pruritus by Topical Doxycycline
RandomizedSingle-groupSingle-blindTreatment
Summary
Investigators will study the effects of topical doxycycline on cutaneous allergic early and late phase responses by determining allergen skin responses in each subject after a single application to allergen induced allergic swelling of 2% doxycycline in emollient.
Timeline
- Start
- 2019-05-15
- Primary completion
- 2022-05-14
- Completion
- 2022-05-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Doxycycline | Small molecule | 2 % | Topical |